Abstract:Twenty-five to thirty percent of patients with node-negative breast cancer are expected to relapse following surgery, therefore great efforts have been made to identify new prognostic markers that could be useful in defining patients for additional therapy. The expression of MMP-2 and MMP-9 has been associated with high potential of metastasis in several human carcinomas including breast cancer. In the present study we examined the prognostic value of immunoreactive MMP-2/MMP-9 protein in 270 consecutive lymph node negative cases who received radical mastectomy or modified radical mastectomy. Among the patients, 211 cases received adjuvant endocrine therapy and/or adjuvant chemotherapy. Using immunohistochemical assay, we found that 56.7% of the resected tumors were positive for MMP-2 whereas 59.6% of the samples were positive for MMP-9. χ 2 test demonstrated a significant direct association between MMP-2 and MMP-9 ( p < 0.001); positive immunostaining of MMP-2 was significantly related to higher tumor grade ( p < 0.001) and larger tumor size ( p =0.012); positive immunostaining of MMP-9 was significantly related to higher tumor grade ( p =0.002). In univariate analysis, using Cox-proportional hazard model we found MMP-2, MMP-9 and the co-expression of MMPs (MMP2/MMP9) were significantly associated with patients' relapse free survival ( p =0.016, 0.015 and 0.013 respectively) but not overall survival ( p =0.122, 0.320 and 0.091 respectively). Log-rank test also showed that MMP-2, MMP-9 or the co-expression of MMP2/MMP9 was unfavorable prognostic factor for relapse free survival but not overall survival. In subgroup analysis, we found MMPs were more prognostic for patients with no adjuvant treatment than for patients with adjuvant therapy. In multivariate analysis, using Cox-proportional hazard model we found co-expression of MMPs, larger tumor size and higher tumor grade were unfavorable for relapse free survival ( p =0.038, 0.007 and 0.015 for each). We concluded that MMP-2 and MMP-2 are unfavorable prognostic factors in breast cancer patients. They might be potential predictive factor for adjuvant systemic therapy. The co-expression of MMP-2 and MMP-9 has significantly prognostic value in node-negative patients.

Deregulation of MMP-2 and MMP-9 in laryngeal cancer: A retrospective observational study

Dysregulated Micrornas in Laryngeal Cancer: a Comprehensive Meta-Analysis Using a Robust Rank Aggregation Approach.

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Meta-analysis of expression and significance of metal matrix proteinase-2 in laryngeal squamous cell carcinoma based on immunohistochemistry

[Expressions of HMGB1, MMP-2 and MMP-9 and Prognostic Alue in Human Laryngeal Carcinoma].

Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma

Mmp2/3 Promote The Growth And Migration Of Laryngeal Squamous Cell Carcinoma Via Pi3k/Akt-Nf-B-Mediated Epithelial-Mesenchymal Transformation

Correlation of Matrix Metalloproteinase-2, −9, Tissue Inhibitor-1 of Matrix Metalloproteinase and CD44 Variant 6 in Head and Neck Cancer Metastasis

Prognostic Value of Matrix Metalloproteinases (MMP-2 and MMP-9) in Patients with Lymph Node-Negative Breast Carcinoma

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

MMP12 serves as an immune cell–related marker of disease status and prognosis in lung squamous cell carcinoma

The Role of Matrix Metalloproteinase Expression in Lung Cancer Metastasis

Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Expression of Membrane Type 1-Matrix Metalloproteinase in Laryngeal Carcinoma

The Relationship Between the Expression ofMetalloproteinase- 2 and Laryngeal Squamous Cell Carcinoma

Association of Smoking and XPG, CYP1A1, OGG1, ERCC5, ERCC1, MMP2, and MMP9 Gene Polymorphisms with the early detection and occurrence of Laryngeal Squamous Carcinoma.

STUDY ON EXPRESSION AND SIGNIFICANCE OF MMP-9 AND PCNA IN CERVICAL CARCINOMA BY TISSUE MICROARRAY

Immunoexpression of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Metastasis of Squamous Cell Carcinoma of the Human Tongue

Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients

MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway